Lakeside Advisors’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-95,280
| Closed | -$400K | – | 62 |
|
2023
Q1 | $400K | Hold |
95,280
| – | – | 0.31% | 43 |
|
2022
Q4 | $573K | Hold |
95,280
| – | – | 0.47% | 34 |
|
2022
Q3 | $555K | Sell |
95,280
-2,500
| -3% | -$14.6K | 0.5% | 32 |
|
2022
Q2 | $584K | Hold |
97,780
| – | – | 0.5% | 32 |
|
2022
Q1 | $457K | Hold |
97,780
| – | – | 0.34% | 36 |
|
2021
Q4 | $242K | Buy |
+97,780
| New | +$242K | 0.18% | 49 |
|